Comparison Chart Tenax Therapeutics, Inc.

Stocks

TENX

US88032L6056

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-09-04 EDT			5-day change	1st Jan Change
1.940 ^USD	+8.99%		-8.92%	-84.09%

08-31	Guggenheim Downgrades Tenax Therapeutics to Neutral From Buy	MT
08-29	Tenax Therapeutics Presents Additional Results from Phase 3 Level Clinical Trial Evaluating Tnx-103 in Patients with Pulmonary Hypertension Due to Heart Failure with Preserved Ejection Fraction	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	TENAX THERAPEUTICS, INC.	Other Biotechnology & Medical Research	+8.99%	-8.92%	-84.09%	-67.67%	-99.92%	102M